Novozymes A/S (OTCMKTS:NVZMY – Get Free Report)’s share price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $62.76 and traded as high as $64.55. Novozymes A/S shares last traded at $63.00, with a volume of 16,296 shares.
Wall Street Analyst Weigh In
Separately, Zacks Research downgraded shares of Novozymes A/S from a “strong-buy” rating to a “hold” rating in a report on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy”.
Check Out Our Latest Report on NVZMY
Novozymes A/S Stock Down 1.8%
Novozymes A/S Cuts Dividend
The business also recently declared a dividend, which was paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd were given a dividend of $0.1856 per share. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S’s dividend payout ratio is 23.42%.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Read More
- Five stocks we like better than Novozymes A/S
- How is Compound Interest Calculated?
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Find and Profitably Trade Stocks at 52-Week Lows
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- The Risks of Owning Bonds
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.